18-12311033-G-A
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 0P and 4B. BS2
The NM_032525.3(TUBB6):c.257G>A(p.Arg86Gln) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000228 in 1,612,828 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_032525.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000789 AC: 12AN: 152000Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000116 AC: 29AN: 250854Hom.: 0 AF XY: 0.000118 AC XY: 16AN XY: 135690
GnomAD4 exome AF: 0.000244 AC: 356AN: 1460828Hom.: 0 Cov.: 30 AF XY: 0.000226 AC XY: 164AN XY: 726704
GnomAD4 genome AF: 0.0000789 AC: 12AN: 152000Hom.: 0 Cov.: 32 AF XY: 0.0000808 AC XY: 6AN XY: 74236
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.257G>A (p.R86Q) alteration is located in exon 3 (coding exon 3) of the TUBB6 gene. This alteration results from a G to A substitution at nucleotide position 257, causing the arginine (R) at amino acid position 86 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
not provided Uncertain:1
The TUBB6 p.Arg86Gln variant was not identified in the literature nor was it identified in ClinVar, Cosmic, or LOVD 3.0. The variant was identified in dbSNP (ID: rs143181795) and was also found in control databases in 29 of 250854 chromosomes at a frequency of 0.000116 (Genome Aggregation Database Feb 27, 2017). The variant was observed in the following populations: European (non-Finnish) in 25 of 113530 chromosomes (freq: 0.00022), African in 3 of 16232 chromosomes (freq: 0.000185) and East Asian in 1 of 18324 chromosomes (freq: 0.000055), while the variant was not observed in the Latino, Ashkenazi Jewish, European (Finnish), Other and South Asian populations. The variant occurs outside of the splicing consensus sequence and in silico or computational prediction software programs (SpliceSiteFinder, MaxEntScan, NNSPLICE, GeneSplicer) do not predict a difference in splicing. The p.Arg86 residue is conserved in mammals and computational analyses (PolyPhen-2, SIFT, AlignGVGD, BLOSUM, MutationTaster) provide inconsistent predictions regarding the impact to the protein; this information is not very predictive of pathogenicity. In summary, based on the above information the clinical significance of this variant cannot be determined with certainty at this time. This variant is classified as a variant of uncertain significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at